ESC Premium Access

Platelet hypo-responsiveness to nitric oxide in new onset atrial fibrillation has a physiological, as opposed to pharmacological, basis.

Congress Presentation

About the speaker

Doctor Nathan Procter

Royal Australasian College of Surgeons, Kent Town (Australia)
0 follower

28 more presentations in this session

Increased arrhythmia stability is associated with risk-factor specific structural remodelling in a porcine model of arterial hypertension and atrial fibrillation

Speaker: Doctor M. Manninger (Graz, AT)

Thumbnail

Inhibition of small conductance Ca2+-activated K+-Channels converts and prevents reinduction of atrial fibrillation in pigs where vernakalant fails

Speaker: Doctor J. Diness (Copenhagen, DK)

Thumbnail

Inducibility of atrial fibrillation after epicardial injection of the new pharmaceutical composition containing botulinum toxin into epicardial fat pads

Speaker: Doctor A. Romanov (Novosibirsk, RU)

Thumbnail

Glucagon-like-peptide-1 (GLP-1) Suppresses the Induction of Atrial Fibrillation in Canine Model of Atrial Fibrillation.

Speaker: Doctor H. Nakamura (Sagamihara, JP)

Thumbnail

Can we predict the effect of antiarrhythmic pharmacotherapy in atrial fibrillation and metabolic syndrome patients: focus on galectin-3

Speaker: Assistant Professor V. Ionin (Saint-Petersburg, RU)

Thumbnail

Access the full session

Poster session 5 - Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Speakers: Doctor N. Procter, Doctor M. Manninger, Doctor J. Diness, Doctor A. Romanov, Doctor H. Nakamura...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations